BENDAMUSTINE HYDROCHLORIDE

BENDAMUSTINE HYDROCHLORIDE was reported 8517 times

These side effects are most commonly reported by patients taking BENDAMUSTINE HYDROCHLORIDE:

# Side effect Count
0 OFF LABEL USE 1135
1 PYREXIA 865
2 DISEASE PROGRESSION 572
3 RASH 558
4 FEBRILE NEUTROPENIA 534
5 NEUTROPENIA 501
6 PNEUMONIA 468
7 DRUG INEFFECTIVE 451
8 PLATELET COUNT DECREASED 442
9 DEATH 425
10 NEUTROPHIL COUNT DECREASED 424
11 PRODUCT USE IN UNAPPROVED INDICATION 416
12 COVID-19 412
13 ANAEMIA 395
14 PANCYTOPENIA 386
15 MALIGNANT NEOPLASM PROGRESSION 380
16 NAUSEA 373
17 THROMBOCYTOPENIA 367
18 WHITE BLOOD CELL COUNT DECREASED 352
19 DIARRHOEA 336
20 FATIGUE 308
21 MYELOSUPPRESSION 282
22 PRESCRIBED UNDERDOSE 276
23 CYTOMEGALOVIRUS INFECTION 271
24 LYMPHOCYTE COUNT DECREASED 263
25 INFUSION RELATED REACTION 262
26 SEPSIS 258
27 DYSPNOEA 237
28 VOMITING 223
29 INFECTION 221
30 ASTHENIA 216
31 HYPOTENSION 211
32 CHILLS 204
33 NEUROPATHY PERIPHERAL 193
34 DECREASED APPETITE 189
35 PRODUCT USE ISSUE 187
36 ACUTE KIDNEY INJURY 184
37 BLOOD LACTATE DEHYDROGENASE INCREASED 182
38 CYTOPENIA 174
39 DIFFUSE LARGE B-CELL LYMPHOMA 174
40 ATRIAL FIBRILLATION 164
41 HYPERSENSITIVITY 156
42 ERYTHEMA 154
43 PRURITUS 151
44 TUMOUR LYSIS SYNDROME 148
45 COVID-19 PNEUMONIA 146
46 SEPTIC SHOCK 133
47 MALAISE 132
48 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 132
49 LYMPHADENOPATHY 130
50 COUGH 127
51 HYPOGAMMAGLOBULINAEMIA 127
52 PLEURAL EFFUSION 127
53 HERPES ZOSTER 125
54 ABDOMINAL PAIN 124
55 DEHYDRATION 123
56 MYELODYSPLASTIC SYNDROME 121
57 GENERAL PHYSICAL HEALTH DETERIORATION 116
58 WEIGHT DECREASED 116
59 BONE MARROW FAILURE 115
60 CONSTIPATION 115
61 HAEMOGLOBIN DECREASED 114
62 RASH MACULO-PAPULAR 111
63 HEADACHE 109
64 CHRONIC LYMPHOCYTIC LEUKAEMIA 108
65 BLOOD PRESSURE DECREASED 107
66 PAIN 107
67 RESPIRATORY FAILURE 104
68 PLASMA CELL MYELOMA 102
69 LEUKOPENIA 100
70 RENAL FAILURE 100
71 THERAPY PARTIAL RESPONDER 97
72 ACUTE MYELOID LEUKAEMIA 95
73 INTERSTITIAL LUNG DISEASE 94
74 EXTRAVASATION 93
75 ALANINE AMINOTRANSFERASE INCREASED 90
76 CYTOKINE RELEASE SYNDROME 90
77 DIZZINESS 90
78 ASPARTATE AMINOTRANSFERASE INCREASED 89
79 LYMPHOPENIA 89
80 CYTOMEGALOVIRUS CHORIORETINITIS 88
81 END STAGE RENAL DISEASE 88
82 RENAL IMPAIRMENT 88
83 LYMPHOMA 87
84 ALOPECIA 86
85 CONDITION AGGRAVATED 86
86 NEOPLASM PROGRESSION 84
87 HEPATIC FUNCTION ABNORMAL 83
88 INTENTIONAL PRODUCT USE ISSUE 83
89 CD4 LYMPHOCYTES DECREASED 81
90 PULMONARY EMBOLISM 81
91 STOMATITIS 81
92 STEVENS-JOHNSON SYNDROME 80
93 BACK PAIN 79
94 INFUSION SITE PAIN 79
95 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78
96 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 77
97 URINARY TRACT INFECTION 76
98 CONFUSIONAL STATE 75
99 DRUG HYPERSENSITIVITY 75
100 FALL 75
101 BACTERAEMIA 74
102 C-REACTIVE PROTEIN INCREASED 74
103 RASH PRURITIC 74
104 CARDIAC DISORDER 73
105 CYTOMEGALOVIRUS INFECTION REACTIVATION 73
106 TOXICITY TO VARIOUS AGENTS 73
107 URTICARIA 72
108 CORONAVIRUS INFECTION 71
109 INFUSION SITE EXTRAVASATION 71
110 PNEUMOCYSTIS JIROVECII PNEUMONIA 71
111 BLOOD CREATININE INCREASED 70
112 TACHYCARDIA 68
113 ARTHRALGIA 67
114 CYTOMEGALOVIRUS VIRAEMIA 67
115 CARDIAC FAILURE 66
116 MUCOSAL INFLAMMATION 66
117 HYPERTENSION 64
118 SECOND PRIMARY MALIGNANCY 63
119 TREATMENT FAILURE 63
120 FLUSHING 62
121 SYNCOPE 62
122 BASAL CELL CARCINOMA 60
123 HYPOKALAEMIA 60
124 EOSINOPHILIA 59
125 HAEMATOTOXICITY 59
126 OEDEMA PERIPHERAL 59
127 APLASIA PURE RED CELL 58
128 HYPERCALCAEMIA 58
129 MANTLE CELL LYMPHOMA RECURRENT 58
130 CYTOMEGALOVIRUS TEST POSITIVE 57
131 PAIN IN EXTREMITY 57
132 THERAPY NON-RESPONDER 57
133 AGRANULOCYTOSIS 56
134 DRUG ERUPTION 56
135 LIVER DISORDER 56
136 NON-HODGKIN^S LYMPHOMA 56
137 CHEST PAIN 55
138 INFLUENZA 54
139 BRONCHITIS 53
140 HAEMOLYTIC ANAEMIA 53
141 MYOCARDIAL INFARCTION 53
142 ANAPHYLACTIC REACTION 52
143 DRUG INTOLERANCE 52
144 RASH ERYTHEMATOUS 52
145 HYPOXIA 51
146 MANTLE CELL LYMPHOMA 51
147 TREMOR 51
148 INSOMNIA 50
149 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50
150 DRUG RESISTANCE 49
151 METASTASIS 49
152 CARDIAC ARREST 48
153 INFUSION SITE REACTION 48
154 THERAPEUTIC RESPONSE DECREASED 48
155 FOLLICULAR LYMPHOMA 47
156 BRONCHOPULMONARY ASPERGILLOSIS 46
157 CYTOMEGALOVIRUS ENTEROCOLITIS 46
158 NEUTROPENIC SEPSIS 46
159 PNEUMONITIS 46
160 BLOOD COUNT ABNORMAL 45
161 COLITIS 45
162 DISSEMINATED INTRAVASCULAR COAGULATION 45
163 ORGANISING PNEUMONIA 45
164 RED BLOOD CELL COUNT DECREASED 45
165 SQUAMOUS CELL CARCINOMA 45
166 CANDIDA INFECTION 43
167 ILEUS 43
168 PHLEBITIS 43
169 MYALGIA 42
170 RASH GENERALISED 42
171 STAPHYLOCOCCAL INFECTION 42
172 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41
173 OEDEMA 41
174 PARAESTHESIA 41
175 BLOOD PRESSURE INCREASED 40
176 CELLULITIS 40
177 DISEASE RECURRENCE 40
178 NASOPHARYNGITIS 40
179 RENAL FAILURE ACUTE 40
180 AUTOIMMUNE HAEMOLYTIC ANAEMIA 39
181 DEEP VEIN THROMBOSIS 39
182 DISORIENTATION 39
183 NON-HODGKIN^S LYMPHOMA RECURRENT 39
184 PERIPHERAL SWELLING 39
185 SPLENOMEGALY 39
186 FEAR OF INJECTION 38
187 INFUSION SITE IRRITATION 38
188 MYOSITIS 38
189 VIRAL INFECTION 38
190 WEIGHT INCREASED 38
191 ASCITES 37
192 DEPRESSION 37
193 DERMATITIS 37
194 INJECTION SITE PAIN 37
195 HAEMORRHAGE 36
196 HYPERHIDROSIS 36
197 INFLAMMATION 36
198 LYMPHOMA TRANSFORMATION 36
199 PNEUMONIA CYTOMEGALOVIRAL 36
200 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36
201 VASCULITIS 36
202 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35
203 HEPATIC ENZYME INCREASED 35
204 LUNG DISORDER 35
205 WHITE BLOOD CELL COUNT INCREASED 35
206 B-CELL LYMPHOMA 34
207 DRUG INTERACTION 34
208 SKIN EXFOLIATION 34
209 FUNGAL INFECTION 33
210 HEART RATE INCREASED 33
211 HEPATITIS 33
212 NEUROLOGICAL SYMPTOM 33
213 PULMONARY FIBROSIS 33
214 ABDOMINAL DISCOMFORT 32
215 BURNING SENSATION 32
216 GASTROINTESTINAL DISORDER 32
217 HYDRONEPHROSIS 32
218 BACTERIAL INFECTION 31
219 CHEST DISCOMFORT 31
220 DYSPHAGIA 31
221 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31
222 HEPATITIS B REACTIVATION 31
223 HODGKIN^S DISEASE 31
224 HYPOAESTHESIA 31
225 PSEUDOMONAS INFECTION 31
226 PULMONARY OEDEMA 31
227 RESPIRATORY DISTRESS 31
228 SKIN REACTION 31
229 TOXIC SKIN ERUPTION 31
230 HEPATITIS B 30
231 HYPOAESTHESIA ORAL 30
232 MUSCULAR WEAKNESS 30
233 PNEUMONIA BACTERIAL 30
234 RESPIRATORY TRACT INFECTION 30
235 ABDOMINAL PAIN UPPER 29
236 BLINDNESS 29
237 DELIRIUM 29
238 HAEMATOCRIT DECREASED 29
239 SKIN DISORDER 29
240 THROMBOSIS 29
241 BLOOD BILIRUBIN INCREASED 28
242 DEVICE RELATED INFECTION 28
243 GLOMERULAR FILTRATION RATE DECREASED 28
244 INFUSION SITE SWELLING 28
245 LOSS OF CONSCIOUSNESS 28
246 LUNG INFECTION 28
247 PANCREATITIS 28
248 POST-ACUTE COVID-19 SYNDROME 28
249 SINUSITIS 28
250 VASOGENIC CEREBRAL OEDEMA 28
251 ARRHYTHMIA 27
252 INFUSION SITE ERYTHEMA 27
253 INFUSION SITE PHLEBITIS 27
254 JOINT SWELLING 27
255 ORAL CANDIDIASIS 27
256 SQUAMOUS CELL CARCINOMA OF SKIN 27
257 BLISTER 26
258 ENTEROCOCCAL INFECTION 26
259 GASTROINTESTINAL HAEMORRHAGE 26
260 HAEMOLYSIS 26
261 HYPERKALAEMIA 26
262 HYPERTHERMIA 26
263 LIVER FUNCTION TEST ABNORMAL 26
264 NEPHROPATHY TOXIC 26
265 SKIN LESION 26
266 CARDIAC FAILURE CONGESTIVE 25
267 DRUG EFFECT INCOMPLETE 25
268 ERYTHROPOIESIS ABNORMAL 25
269 HEPATIC FAILURE 25
270 IMMUNE SYSTEM DISORDER 25
271 IMMUNE THROMBOCYTOPENIC PURPURA 25
272 MUSCLE SPASMS 25
273 PNEUMONIA ASPIRATION 25
274 RASH PAPULAR 25
275 ASPERGILLUS INFECTION 24
276 ATELECTASIS 24
277 CLOSTRIDIUM DIFFICILE COLITIS 24
278 GENERALISED OEDEMA 24
279 HYPONATRAEMIA 24
280 IMMUNOSUPPRESSION 24
281 INTESTINAL OBSTRUCTION 24
282 MUSCULOSKELETAL STIFFNESS 24
283 RASH MACULAR 24
284 ULCER 24
285 UROSEPSIS 24
286 VENOOCCLUSIVE LIVER DISEASE 24
287 ACUTE MYOCARDIAL INFARCTION 23
288 ARTHRITIS 23
289 BONE PAIN 23
290 DERMATITIS EXFOLIATIVE GENERALISED 23
291 GAIT DISTURBANCE 23
292 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 23
293 JAUNDICE 23
294 ORAL FUNGAL INFECTION 23
295 PERICARDIAL EFFUSION 23
296 PERIPHERAL SENSORY NEUROPATHY 23
297 ACUTE RESPIRATORY DISTRESS SYNDROME 22
298 ACUTE RESPIRATORY FAILURE 22
299 ANAPHYLACTIC SHOCK 22
300 CARDIOMYOPATHY 22
301 CYSTITIS 22
302 DIABETES MELLITUS 22
303 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22
304 OPPORTUNISTIC INFECTION 22
305 PALPITATIONS 22
306 RENAL DISORDER 22
307 SKIN NECROSIS 22
308 STAPHYLOCOCCAL BACTERAEMIA 22
309 TOXIC EPIDERMAL NECROLYSIS 22
310 ANXIETY 21
311 BLOOD ALKALINE PHOSPHATASE INCREASED 21
312 BLOOD GLUCOSE INCREASED 21
313 BODY TEMPERATURE INCREASED 21
314 CYTOMEGALOVIRUS COLITIS 21
315 DRY EYE 21
316 ENTEROCOLITIS 21
317 FEELING ABNORMAL 21
318 GOUT 21
319 HAEMATURIA 21
320 HYPERBILIRUBINAEMIA 21
321 NEUROTOXICITY 21
322 OROPHARYNGEAL PAIN 21
323 OXYGEN SATURATION DECREASED 21
324 POLYNEUROPATHY 21
325 PSYCHOTIC DISORDER 21
326 RHEUMATOID ARTHRITIS 21
327 THERAPEUTIC PRODUCT EFFECT DECREASED 21
328 UPPER RESPIRATORY TRACT INFECTION 21
329 URINARY RETENTION 21
330 VENTRICULAR TACHYCARDIA 21
331 ABDOMINAL DISTENSION 20
332 BLOOD IMMUNOGLOBULIN G DECREASED 20
333 BREATH SOUNDS ABNORMAL 20
334 CHOLELITHIASIS 20
335 CHOLESTASIS 20
336 DYSGEUSIA 20
337 ENCEPHALOPATHY 20
338 FEBRILE BONE MARROW APLASIA 20
339 GASTROINTESTINAL TOXICITY 20
340 HYPERGLYCAEMIA 20
341 HYPOPHAGIA 20
342 ILL-DEFINED DISORDER 20
343 KLEBSIELLA INFECTION 20
344 PANNICULITIS 20
345 SUICIDE ATTEMPT 20
346 CEREBRAL HAEMORRHAGE 19
347 CEREBROVASCULAR ACCIDENT 19
348 CLOSTRIDIUM DIFFICILE INFECTION 19
349 DYSARTHRIA 19
350 ERYSIPELAS 19
351 FLATULENCE 19
352 IMMUNODEFICIENCY 19
353 LETHARGY 19
354 LEUKOCYTOSIS 19
355 LUNG INFILTRATION 19
356 NERVOUS SYSTEM DISORDER 19
357 SKIN ULCER 19
358 SUBDURAL HAEMATOMA 19
359 APLASTIC ANAEMIA 18
360 ARTHROPATHY 18
361 BLOOD TEST ABNORMAL 18
362 BLOOD URIC ACID INCREASED 18
363 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18
364 HEPATOTOXICITY 18
365 HYPOCALCAEMIA 18
366 NEOPLASM 18
367 OBLITERATIVE BRONCHIOLITIS 18
368 RED BLOOD CELL SEDIMENTATION RATE INCREASED 18
369 RICHTER^S SYNDROME 18
370 SWELLING 18
371 SWELLING FACE 18
372 TUBULOINTERSTITIAL NEPHRITIS 18
373 ACUTE CORONARY SYNDROME 17
374 BLOOD PARATHYROID HORMONE DECREASED 17
375 C-REACTIVE PROTEIN ABNORMAL 17
376 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 17
377 CONTUSION 17
378 DIVERTICULITIS 17
379 DRUG TOLERANCE 17
380 DYSPNOEA EXERTIONAL 17
381 ELECTROCARDIOGRAM QT PROLONGED 17
382 FACE OEDEMA 17
383 GRANULOMA SKIN 17
384 HYPOALBUMINAEMIA 17
385 IMMUNE THROMBOCYTOPENIA 17
386 LOWER RESPIRATORY TRACT INFECTION 17
387 ORAL DISORDER 17
388 PNEUMONIA FUNGAL 17
389 PNEUMONIA PSEUDOMONAL 17
390 RHEUMATOID FACTOR POSITIVE 17
391 RHEUMATOID NODULE 17
392 SYNOVITIS 17
393 TACHYPNOEA 17
394 THROMBOTIC MICROANGIOPATHY 17
395 UNEVALUABLE EVENT 17
396 URINARY TRACT INFECTION BACTERIAL 17
397 VARICELLA ZOSTER VIRUS INFECTION 17
398 CARDIO-RESPIRATORY ARREST 16
399 DRY SKIN 16
400 DYSPEPSIA 16
401 ECZEMA 16
402 EJECTION FRACTION DECREASED 16
403 GUILLAIN-BARRE SYNDROME 16
404 HEPATIC CIRRHOSIS 16
405 HYPOMAGNESAEMIA 16
406 MENTAL STATUS CHANGES 16
407 MULTI-ORGAN FAILURE 16
408 MULTIPLE MYELOMA 16
409 NEOPLASM RECURRENCE 16
410 NEUROENDOCRINE CARCINOMA OF THE SKIN 16
411 NO ADVERSE EVENT 16
412 NODULE 16
413 PEMPHIGOID 16
414 RED CELL DISTRIBUTION WIDTH INCREASED 16
415 SERUM SICKNESS 16
416 SHOCK 16
417 SKIN NEOPLASM EXCISION 16
418 SKIN TOXICITY 16
419 STAPHYLOCOCCAL SEPSIS 16
420 WALDENSTROM^S MACROGLOBULINAEMIA 16
421 ALTERED STATE OF CONSCIOUSNESS 15
422 ATRIAL FLUTTER 15
423 BACTERIAL SEPSIS 15
424 BRADYCARDIA 15
425 CEREBRAL INFARCTION 15
426 CONJUNCTIVITIS 15
427 DERMATITIS EXFOLIATIVE 15
428 DYSURIA 15
429 EMBOLISM 15
430 ESCHERICHIA URINARY TRACT INFECTION 15
431 FULL BLOOD COUNT DECREASED 15
432 HYPERURICAEMIA 15
433 LIVER INJURY 15
434 METASTASES TO LIVER 15
435 OESOPHAGITIS 15
436 SOMNOLENCE 15
437 SUSPECTED OFF LABEL USE 15
438 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15
439 THERAPY RESPONDER 15
440 B-CELL LYMPHOMA RECURRENT 14
441 BLOOD DISORDER 14
442 CYSTITIS HAEMORRHAGIC 14
443 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 14
444 DRY MOUTH 14
445 ENCEPHALITIS 14
446 FEELING COLD 14
447 GRANULOCYTE COUNT DECREASED 14
448 HEPATIC CYTOLYSIS 14
449 LABORATORY TEST ABNORMAL 14
450 MALIGNANT PLEURAL EFFUSION 14
451 MALNUTRITION 14
452 NEOPLASM SKIN 14
453 ORTHOSTATIC HYPOTENSION 14
454 PLASMA CELL MYELOMA REFRACTORY 14
455 PNEUMOCYSTIS JIROVECI PNEUMONIA 14
456 PNEUMOTHORAX 14
457 PROCALCITONIN INCREASED 14
458 RASH MORBILLIFORM 14
459 SARS-COV-2 TEST POSITIVE 14
460 SEIZURE 14
461 TRANSAMINASES INCREASED 14
462 VACCINATION FAILURE 14
463 VEIN DISORDER 14
464 VENOOCCLUSIVE DISEASE 14
465 APLASIA 13
466 B-LYMPHOCYTE COUNT DECREASED 13
467 CEREBRAL ASPERGILLOSIS 13
468 CHRONIC KIDNEY DISEASE 13
469 CIRCULATORY COLLAPSE 13
470 CORONAVIRUS PNEUMONIA 13
471 DEPRESSED LEVEL OF CONSCIOUSNESS 13
472 EPISTAXIS 13
473 ERYTHEMA MULTIFORME 13
474 ESCHERICHIA INFECTION 13
475 FEELING HOT 13
476 FEMORAL NECK FRACTURE 13
477 HERPES SIMPLEX 13
478 HUMORAL IMMUNE DEFECT 13
479 HYPERTRANSAMINASAEMIA 13
480 INTESTINAL PERFORATION 13
481 ISCHAEMIC STROKE 13
482 JC VIRUS INFECTION 13
483 MELAENA 13
484 MENINGITIS 13
485 NON-HODGKIN'S LYMPHOMA 13
486 PRODUCTIVE COUGH 13
487 PSEUDOMEMBRANOUS COLITIS 13
488 PULMONARY HYPERTENSION 13
489 PULMONARY MASS 13
490 RESPIRATORY DISORDER 13
491 SINUS TACHYCARDIA 13
492 URINARY INCONTINENCE 13
493 VISUAL IMPAIRMENT 13
494 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13
495 ADENOVIRUS INFECTION 12
496 ANKYLOSING SPONDYLITIS 12
497 BLOOD POTASSIUM DECREASED 12
498 CARDIAC FAILURE ACUTE 12
499 CLOSTRIDIAL INFECTION 12
500 DEAFNESS 12
501 FLUID RETENTION 12
502 HAEMATOMA 12
503 HEPATITIS E 12
504 HOT FLUSH 12
505 HYPOTONIA 12
506 INGUINAL HERNIA 12
507 INJECTION SITE PHLEBITIS 12
508 LEFT VENTRICULAR DYSFUNCTION 12
509 METASTASES TO CENTRAL NERVOUS SYSTEM 12
510 MYOCARDITIS 12
511 NIGHT SWEATS 12
512 NON-SMALL CELL LUNG CANCER 12
513 PRESCRIBED OVERDOSE 12
514 RENAL TUBULAR NECROSIS 12
515 RHINOVIRUS INFECTION 12
516 SUPRAVENTRICULAR TACHYCARDIA 12
517 TROPONIN INCREASED 12
518 UNDERDOSE 12
519 WHEEZING 12
520 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 11
521 ACUTE HEPATIC FAILURE 11
522 ADRENAL INSUFFICIENCY 11
523 ADVERSE EVENT 11
524 ANURIA 11
525 BLOOD PRESSURE SYSTOLIC INCREASED 11
526 BLOOD UREA INCREASED 11
527 COGNITIVE DISORDER 11
528 CRYPTOCOCCOSIS 11
529 DECREASED IMMUNE RESPONSIVENESS 11
530 DISCOMFORT 11
531 FAILURE TO THRIVE 11
532 GASTROENTERITIS 11
533 HEMIPARESIS 11
534 HEPATIC ENCEPHALOPATHY 11
535 INCORRECT DOSE ADMINISTERED 11
536 INFLAMMATORY MARKER INCREASED 11
537 INFUSION SITE INDURATION 11
538 LUNG NEOPLASM MALIGNANT 11
539 MEMORY IMPAIRMENT 11
540 METABOLIC ACIDOSIS 11
541 METASTASES TO BONE MARROW 11
542 METASTASES TO LUNG 11
543 OESOPHAGEAL CANDIDIASIS 11
544 ORAL HERPES 11
545 OVERDOSE 11
546 PANCREATITIS ACUTE 11
547 PATHOGEN RESISTANCE 11
548 PROSTATE CANCER 11
549 RENAL INJURY 11
550 SMALL INTESTINAL OBSTRUCTION 11
551 SUDDEN DEATH 11
552 SYSTEMIC CANDIDA 11
553 ABDOMINAL PAIN LOWER 10
554 ANAEMIA HAEMOLYTIC AUTOIMMUNE 10
555 ANGIOEDEMA 10
556 APHASIA 10
557 BREAKTHROUGH COVID-19 10
558 CACHEXIA 10
559 CHOLECYSTITIS 10
560 COLON CANCER 10
561 CONTRAINDICATED PRODUCT ADMINISTERED 10
562 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
563 ELECTROLYTE IMBALANCE 10
564 ENCEPHALITIS CYTOMEGALOVIRUS 10
565 ENTEROCOCCAL SEPSIS 10
566 EOSINOPHIL COUNT INCREASED 10
567 FAECALOMA 10
568 FEBRILE INFECTION 10
569 FOLLICULAR LYMPHOMA RECURRENT 10
570 GENERALISED ERYTHEMA 10
571 GRAFT VERSUS HOST DISEASE 10
572 HAEMATOCHEZIA 10
573 HAEMOGLOBIN ABNORMAL 10
574 HOSPITALISATION 10
575 HYPOVOLAEMIA 10
576 INJECTION SITE EXTRAVASATION 10
577 LYMPHOCYTE COUNT INCREASED 10
578 MALIGNANT MELANOMA 10
579 MOUTH ULCERATION 10
580 PERITONITIS 10
581 PLASMA CELL LEUKAEMIA 10
582 PLASMA CELL MYELOMA RECURRENT 10
583 PRODUCT PREPARATION ERROR 10
584 PULMONARY TOXICITY 10
585 REBOUND EFFECT 10
586 SKIN DISCOLOURATION 10
587 TASTE DISORDER 10
588 THROMBOPHLEBITIS 10
589 UPPER GASTROINTESTINAL HAEMORRHAGE 10
590 ABASIA 9
591 ABDOMINAL LYMPHADENOPATHY 9
592 ABSCESS 9
593 ACCIDENTAL EXPOSURE TO PRODUCT 9
594 ADENOCARCINOMA 9
595 AGITATION 9
596 ANGINA PECTORIS 9
597 ANGIOPATHY 9
598 AORTIC VALVE INCOMPETENCE 9
599 APHTHOUS ULCER 9
600 BLADDER CANCER 9
601 BONE MARROW INFILTRATION 9
602 BRONCHIECTASIS 9
603 CANDIDA SEPSIS 9
604 CARDIOTOXICITY 9
605 COLITIS ULCERATIVE 9
606 CYTOMEGALOVIRUS HEPATITIS 9
607 DEMENTIA 9
608 DYSPLASIA 9
609 ENTERITIS 9
610 GASTROINTESTINAL PERFORATION 9
611 GASTROOESOPHAGEAL REFLUX DISEASE 9
612 GENERAL PHYSICAL CONDITION ABNORMAL 9
613 HAEMOPTYSIS 9
614 HEPATITIS VIRAL 9
615 IMMUNODEFICIENCY COMMON VARIABLE 9
616 INJECTION SITE REACTION 9
617 METASTASES TO MUSCLE 9
618 METASTASES TO RETROPERITONEUM 9
619 METASTASES TO SPLEEN 9
620 MOVEMENT DISORDER 9
621 NEUTROPHIL COUNT ABNORMAL 9
622 NON-HODGKIN^S LYMPHOMA REFRACTORY 9
623 NONSPECIFIC REACTION 9
624 ODYNOPHAGIA 9
625 OTITIS MEDIA 9
626 PARESIS 9
627 PERFORMANCE STATUS DECREASED 9
628 PETECHIAE 9
629 PNEUMONIA VIRAL 9
630 POLYCHROMASIA 9
631 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9
632 PULMONARY TUBERCULOSIS 9
633 REFUSAL OF TREATMENT BY PATIENT 9
634 RHINORRHOEA 9
635 SECONDARY IMMUNODEFICIENCY 9
636 SKIN INFECTION 9
637 SPEECH DISORDER 9
638 VISUAL ACUITY REDUCED 9
639 ACUTE PULMONARY OEDEMA 8
640 AMNESIA 8
641 ANAL ABSCESS 8
642 ATAXIA 8
643 BLINDNESS UNILATERAL 8
644 BLOOD LACTIC ACID INCREASED 8
645 BLOOD URINE PRESENT 8
646 BOWEN^S DISEASE 8
647 COLITIS ISCHAEMIC 8
648 DEMYELINATING POLYNEUROPATHY 8
649 DERMATITIS ALLERGIC 8
650 DISTURBANCE IN ATTENTION 8
651 EPSTEIN-BARR VIRUS INFECTION 8
652 EYE SWELLING 8
653 FUNGAL OESOPHAGITIS 8
654 GASTROINTESTINAL FUNGAL INFECTION 8
655 GRANULOCYTOPENIA 8
656 HAEMORRHAGE INTRACRANIAL 8
657 HUMAN POLYOMAVIRUS INFECTION 8
658 HYPOVOLAEMIC SHOCK 8
659 INCORRECT PRODUCT ADMINISTRATION DURATION 8
660 KLEBSIELLA TEST POSITIVE 8
661 LACTIC ACIDOSIS 8
662 LEUKAEMIA CUTIS 8
663 LOBAR PNEUMONIA 8
664 LOCAL SWELLING 8
665 METABOLIC DISORDER 8
666 MOBILITY DECREASED 8
667 MYOPATHY 8
668 NEOPLASM MALIGNANT 8
669 NEUTROPHIL COUNT INCREASED 8
670 NO THERAPEUTIC RESPONSE 8
671 OLIGURIA 8
672 PARANEOPLASTIC PEMPHIGUS 8
673 PLATELET COUNT ABNORMAL 8
674 PRESYNCOPE 8
675 PURPURA 8
676 RECURRENT CANCER 8
677 RESPIRATORY ARREST 8
678 RHABDOMYOLYSIS 8
679 SWOLLEN TONGUE 8
680 TENDERNESS 8
681 THERAPY CESSATION 8
682 THIRST 8
683 TUMOUR FLARE 8
684 TYPE IV HYPERSENSITIVITY REACTION 8
685 VENTRICULAR EXTRASYSTOLES 8
686 VERTIGO 8
687 VIRAL HAEMORRHAGIC CYSTITIS 8
688 ACNE 7
689 ADENOCARCINOMA OF COLON 7
690 ANISOCYTOSIS 7
691 AORTIC DISSECTION 7
692 AORTIC STENOSIS 7
693 ASPERGILLOSIS 7
694 BALANCE DISORDER 7
695 BLOOD CREATINE PHOSPHOKINASE INCREASED 7
696 BLOOD PHOSPHORUS INCREASED 7
697 BRAIN ABSCESS 7
698 CARDIOGENIC SHOCK 7
699 CATARACT 7
700 CEREBRAL TOXOPLASMOSIS 7
701 CROHN^S DISEASE 7
702 DIPLOPIA 7
703 DYSPHONIA 7
704 EATING DISORDER 7
705 ECTHYMA 7
706 ESCHERICHIA BACTERAEMIA 7
707 ESCHERICHIA SEPSIS 7
708 FOLLICULAR LYMPHOMA REFRACTORY 7
709 FRACTURE 7
710 GASTRIC CANCER 7
711 GASTRIC ULCER 7
712 HAEMORRHOIDS 7
713 HALLUCINATION 7
714 HEAD INJURY 7
715 HEPATOCELLULAR INJURY 7
716 HERPES VIRUS INFECTION 7
717 INFECTION IN AN IMMUNOCOMPROMISED HOST 7
718 JAUNDICE CHOLESTATIC 7
719 JC POLYOMAVIRUS TEST POSITIVE 7
720 KIDNEY INFECTION 7
721 LEUKOENCEPHALOPATHY 7
722 LUNG CONSOLIDATION 7
723 LUNG OPACITY 7
724 LYMPHOCYTOSIS 7
725 METASTASES TO LYMPH NODES 7
726 MITRAL VALVE INCOMPETENCE 7
727 MUCOSAL EROSION 7
728 MUSCULOSKELETAL PAIN 7
729 NASAL CONGESTION 7
730 NECK PAIN 7
731 NEUTROPENIC INFECTION 7
732 NOCARDIOSIS 7
733 PALLOR 7
734 PEMPHIGUS 7
735 PLASMACYTOMA 7
736 POST HERPETIC NEURALGIA 7
737 PRINZMETAL ANGINA 7
738 PROTEINURIA 7
739 PULMONARY MYCOSIS 7
740 PYELONEPHRITIS 7
741 RESPIRATORY SYMPTOM 7
742 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7
743 SCROTAL OEDEMA 7
744 SINUS POLYP 7
745 SKIN EROSION 7
746 SPINAL COMPRESSION FRACTURE 7
747 SPINAL FRACTURE 7
748 STREPTOCOCCAL INFECTION 7
749 THERAPY INTERRUPTED 7
750 URETHRAL OBSTRUCTION 7
751 VEIN DISCOLOURATION 7
752 VENTRICULAR FIBRILLATION 7
753 VENTRICULAR HYPOKINESIA 7
754 WOUND NECROSIS 7
755 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7
756 ABDOMINAL SEPSIS 6
757 ACUTE SINUSITIS 6
758 ADVERSE DRUG REACTION 6
759 AMYLASE INCREASED 6
760 APOPTOTIC COLONOPATHY 6
761 ARTHRITIS BACTERIAL 6
762 ATYPICAL PNEUMONIA 6
763 B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT 6
764 BACTERIAL TEST POSITIVE 6
765 BRONCHOPNEUMONIA 6
766 CARDIOMEGALY 6
767 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6
768 COMA 6
769 CONVULSION 6
770 CREATININE RENAL CLEARANCE DECREASED 6
771 CRYOGLOBULINAEMIA 6
772 CYTOLYTIC HEPATITIS 6
773 CYTOMEGALOVIRUS GASTROENTERITIS 6
774 DECREASED ACTIVITY 6
775 DEVICE RELATED SEPSIS 6
776 DRUG DOSE OMISSION 6
777 DRUG LEVEL DECREASED 6
778 EAR INFECTION 6
779 EMPHYSEMA 6
780 EPILEPSY 6
781 FLANK PAIN 6
782 GENERALISED TONIC-CLONIC SEIZURE 6
783 H1N1 INFLUENZA 6
784 HAEMODIALYSIS 6
785 HEART RATE DECREASED 6
786 HEPATIC CANCER 6
787 HERPES ZOSTER DISSEMINATED 6
788 HICCUPS 6
789 HISTIOCYTOSIS HAEMATOPHAGIC 6
790 HYPERPYREXIA 6
791 HYPERTENSIVE CARDIOMYOPATHY 6
792 HYPOGLYCAEMIA 6
793 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6
794 IMPAIRED HEALING 6
795 INFUSION SITE DISCOLOURATION 6
796 INJECTION SITE ERYTHEMA 6
797 LEUKAEMIA 6
798 LICHEN PLANUS 6
799 LIMB DISCOMFORT 6
800 LIP SWELLING 6
801 LISTERIA SEPSIS 6
802 MASS 6
803 MENINGITIS CRYPTOCOCCAL 6
804 NASAL ABSCESS 6
805 NEPHROGENIC DIABETES INSIPIDUS 6
806 NEPHROLITHIASIS 6
807 ORAL LICHEN PLANUS 6
808 PAIN OF SKIN 6
809 POLLAKIURIA 6
810 POLYARTHRITIS 6
811 RED BLOOD CELL COUNT ABNORMAL 6
812 RETCHING 6
813 SINUS BRADYCARDIA 6
814 SKIN FISSURES 6
815 SKIN SWELLING 6
816 SPINAL CORD INJURY 6
817 SUBARACHNOID HAEMORRHAGE 6
818 THROAT IRRITATION 6
819 THROAT TIGHTNESS 6
820 TINNITUS 6
821 TOOTH EXTRACTION 6
822 TRANSIENT ISCHAEMIC ATTACK 6
823 UPPER LIMB FRACTURE 6
824 VASCULAR PAIN 6
825 VISION BLURRED 6
826 WHITE BLOOD CELL COUNT ABNORMAL 6
827 ABNORMAL DREAMS 5
828 ACARODERMATITIS 5
829 ACUTE GRAFT VERSUS HOST DISEASE 5
830 ADENOCARCINOMA GASTRIC 5
831 ALOPECIA SCARRING 5
832 ANAEMIA MACROCYTIC 5
833 APATHY 5
834 APPENDICITIS 5
835 ASCENDING FLACCID PARALYSIS 5
836 ASPIRATION BONE MARROW ABNORMAL 5
837 ASTHMA 5
838 BK VIRUS INFECTION 5
839 BLISTER RUPTURE 5
840 BLOOD CULTURE POSITIVE 5
841 BLOOD POTASSIUM INCREASED 5
842 BLOOD SODIUM DECREASED 5
843 BONE MARROW DISORDER 5
844 CARDIAC TAMPONADE 5
845 CHRONIC GRAFT VERSUS HOST DISEASE 5
846 CHRONIC MYELOMONOCYTIC LEUKAEMIA 5
847 COAGULATION FACTOR V LEVEL DECREASED 5
848 CYANOSIS 5
849 CYSTITIS VIRAL 5
850 DEAFNESS NEUROSENSORY 5
851 DIVERTICULAR PERFORATION 5
852 DRUG-INDUCED LIVER INJURY 5
853 ENTEROVIRUS INFECTION 5
854 EPSTEIN-BARR VIRAEMIA 5
855 EXPOSURE VIA CONTAMINATED DEVICE 5
856 EYE IRRITATION 5
857 EYELID PTOSIS 5
858 FEMUR FRACTURE 5
859 FULL BLOOD COUNT ABNORMAL 5
860 GASTRITIS 5
861 GASTROINTESTINAL INFECTION 5
862 GITELMAN^S SYNDROME 5
863 GRANULOMA 5
864 HEPATITIS FULMINANT 5
865 HYPERLACTACIDAEMIA 5
866 HYPOPHOSPHATAEMIA 5
867 HYPOTHYROIDISM 5
868 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5
869 ILLNESS 5
870 INCORRECT DRUG ADMINISTRATION DURATION 5
871 INFUSION SITE DISCOMFORT 5
872 INFUSION SITE OEDEMA 5
873 INJECTION SITE MASS 5
874 INTENTIONAL OVERDOSE 5
875 KLEBSIELLA SEPSIS 5
876 LANGERHANS^ CELL HISTIOCYTOSIS 5
877 LIPASE INCREASED 5
878 LISTERIOSIS 5
879 LIVER FUNCTION TEST INCREASED 5
880 LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA RECURRENT 5
881 MENINGITIS ASEPTIC 5
882 METASTASES TO MENINGES 5
883 MOTOR DYSFUNCTION 5
884 MUCORMYCOSIS 5
885 MYOCARDIAL ISCHAEMIA 5
886 NECROSIS 5
887 NEURALGIA 5
888 ORGAN FAILURE 5
889 ORTHOSTATIC INTOLERANCE 5
890 OSTEOARTHRITIS 5
891 OSTEONECROSIS OF JAW 5
892 OSTEOSCLEROSIS 5
893 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5
894 PARALYSIS 5
895 PERICARDITIS 5
896 PERIPHERAL MOTOR NEUROPATHY 5
897 PERONEAL NERVE PALSY 5
898 PNEUMOCOCCAL INFECTION 5
899 PNEUMONIA ESCHERICHIA 5
900 PNEUMONIA INFLUENZAL 5
901 PNEUMONIA PNEUMOCOCCAL 5
902 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5
903 PRODUCT DOSE OMISSION ISSUE 5
904 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5
905 PRODUCT PRESCRIBING ISSUE 5
906 PRURITUS GENERALISED 5
907 PSEUDOMONAL SEPSIS 5
908 PSYCHOMOTOR SKILLS IMPAIRED 5
909 PULMONARY CONGESTION 5
910 RASH PUSTULAR 5
911 RETINITIS 5
912 SKIN CANCER 5
913 SKIN HAEMORRHAGE 5
914 STREPTOCOCCAL BACTERAEMIA 5
915 SUBCUTANEOUS ABSCESS 5
916 THROMBOPHLEBITIS SUPERFICIAL 5
917 TOOTH ABSCESS 5
918 TRICUSPID VALVE INCOMPETENCE 5
919 TUMOUR OBSTRUCTION 5
920 UNRESPONSIVE TO STIMULI 5
921 UPPER RESPIRATORY TRACT INFLAMMATION 5
922 URINE OUTPUT DECREASED 5
923 VASCULAR DEVICE INFECTION 5
924 VASCULITIC RASH 5
925 VITREOUS FLOATERS 5
926 VULVAL DISORDER 5
927 ABDOMINAL MASS 4
928 ABNORMAL BEHAVIOUR 4
929 ABNORMAL WEIGHT GAIN 4
930 ACTIVITIES OF DAILY LIVING IMPAIRED 4
931 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
932 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4
933 ADMINISTRATION SITE EXTRAVASATION 4
934 ANOREXIA 4
935 ASPIRATION 4
936 ATRIOVENTRICULAR BLOCK 4
937 ATYPICAL MYCOBACTERIAL INFECTION 4
938 ATYPICAL MYCOBACTERIAL PNEUMONIA 4
939 AZOTAEMIA 4
940 BETA 2 MICROGLOBULIN INCREASED 4
941 BIOPSY BONE MARROW ABNORMAL 4
942 BLOOD BILIRUBIN DECREASED 4
943 BLOOD GLUCOSE DECREASED 4
944 BLOOD MAGNESIUM DECREASED 4
945 BONE LESION 4
946 BREAST CANCER 4
947 BREAST CANCER METASTATIC 4
948 CANDIDIASIS 4
949 CAPILLARY LEAK SYNDROME 4
950 CARDIAC FAILURE CHRONIC 4
951 CARDIOVASCULAR DISORDER 4
952 CELL-MEDIATED IMMUNE DEFICIENCY 4
953 CENTRAL NERVOUS SYSTEM LYMPHOMA 4
954 CEREBRAL ISCHAEMIA 4
955 CHONDROSARCOMA METASTATIC 4
956 CHRONIC SINUSITIS 4
957 CHYLOTHORAX 4
958 CLOSTRIDIAL SEPSIS 4
959 COLD SWEAT 4
960 CONGENITAL APLASIA 4
961 CORONARY ARTERY DISEASE 4
962 CUTANEOUS VASCULITIS 4
963 DEBRIDEMENT 4
964 DEMYELINATION 4
965 DERMATITIS BULLOUS 4
966 DIFFUSE ALVEOLAR DAMAGE 4
967 DRUG LEVEL BELOW THERAPEUTIC 4
968 DUODENITIS 4
969 DYSSTASIA 4
970 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4
971 ELECTRODESICCATION 4
972 EMBOLISM VENOUS 4
973 ENDOCARDITIS 4
974 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
975 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4
976 ERYTHEMA ANNULARE 4
977 EVANS SYNDROME 4
978 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 4
979 EYE DISORDER 4
980 FLUID INTAKE REDUCED 4
981 FUNGAL TEST POSITIVE 4
982 GASTROENTERITIS NOROVIRUS 4
983 GASTROINTESTINAL INJURY 4
984 GIANT CELL ARTERITIS 4
985 GINGIVAL BLEEDING 4
986 GLOMERULONEPHRITIS 4
987 GROIN PAIN 4
988 HEAD DISCOMFORT 4
989 HEPATITIS CHOLESTATIC 4
990 HYPERLEUKOCYTOSIS 4
991 HYPERNATRAEMIA 4
992 HYPERTENSIVE CRISIS 4
993 HYPERVENTILATION 4
994 HYPOGEUSIA 4
995 HYPOTHERMIA 4
996 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4
997 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
998 INCONTINENCE 4
999 INCORRECT DRUG ADMINISTRATION RATE 4